Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

116. Johnson P N, Boyles K A, Miller J L. Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children. Pharmacotherapy. 2012; 32 : 148-57

117. Miller J L, Nandyal R R, Anderson M, Escobedo M B. Relationship of caffeine dosing with serum alkaline phosphatase levels in extremely low-birth-weight infants. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2012; 17 : 58-66

118. Oldham M M, Miller J L, Hagemann T M, Harrison D, Chavez-Bueno S, Johnson P N. Vancomycin dosage in overweight and obese children. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2011; 68 : 2062-8

119. Miller J L, Hagemann T M. Use of pure opioid antagonists for management of opioid-induced pruritus. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2011; 68 : 1419-25

120. Johnson P N, Miller J L, Gormley A K. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children. Pharmacotherapy. 2011; 31 : 609-20

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

6. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2023.


7. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.


8. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.


9. Rho Chi, Gamma Chapter. 2019 Chapter Alumni Award. Date: 2019.


10. Oklahoma Society of Health-System Pharmacists. Oklahoma Pharmacist of the Year. Date: 2019.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Read More